Colorectal cancer blood test maker Guardant Health has teamed up with “Grey’s Anatomy” star Patrick Dempsey for a new, highly…

Medical device maker Boston Scientific has been a prolific dealmaker this year but is now taking a step back as…

The FDA has approved Freenome’s new blood-based colorectal cancer test, SimpleScreen CRC, which Abbott will exclusively market in the U.S.

Labcorp is launching the Marker by Labcorp Genetic Health Panel, a new direct-to-consumer genetic testing tool that analyzes 163 genes…

Roche’s Diagnostics division continues to battle growth headwinds, notching a 3% increase in sales.

The FDA has authorized Johnson & Johnson’s Ottava Robotic Surgical System as the company looks to compete with Intuitive Surgical…

Dan Malarek is leaving his role as chief executive of Roche’s sequencing subsidiary Foundation Medicine as he takes up the…

Tempus is boosting its cancer offerings with a deal to buy out Personalis three years after the pair first teamed…

Abbott has been struck by several cyberattacks which targeted the medtech giant’s cancer diagnostics and LabCentral businesses.

Abbott turned in a stronger than expected second quarter, allaying market concerns that subsidy cuts to the Affordable Care Act…